INTERSERVE has started work on the new Medicines Manufacturing Innovation Centre (MMIC) in Inchinnan, Renfrewshire after securing a £15 million contract with CPI.
The development will be located near Glasgow Airport and will be led by CPI in partnership with The University of Strathclyde, Scottish Enterprise, UK Research and Innovation and founding industry partners, AstraZeneca and GSK.
Interserve said the centre is being designed to ensure the UK is a ‘technology and innovation leader’ in small molecule pharmaceutical and fine chemical manufacturing.
The MMIC will develop technologies and allow industry, academia, healthcare providers and regulators to work together to address challenges along the medicines supply chain.
The facility is being funded by several sources including UK Research and Innovation through the UK Industrial Strategy Challenge Fund, Scottish Enterprise and GSK and AstraZeneca.
Cameron Stewart, regional director at Interserve Construction, said, “We are delighted to start work on the Medicines Manufacturing Innovation Centre in Scotland bringing our considerable experience to delivering life science projects in the UK including the National Biologics Manufacturing Centre for CPI in Darlington and our work on the new research centre for Genomics Partnership Wales in Cardiff.”
